Radiation Oncology

Select Departments

Research Focus

Research Focus

  • Radio-bio dosimetry 
  • Radio genomics
  • Identifying biomarkers of radiation resistance
  • Radio-proteomics in therapeutic prognosis 
  • Naïve medicine options for treating radiation side effects 

Ongoing studies:

  • Development of Elastin based protein nanogels targeted delivery system of combo drugs Enzalutamide/Decursin for Castration Resistance Prostate Cancer (CRPC) Therapy 
  • Establishment and capacity building for rapid radiation triage and dose estimation using gene expression biomarker 
  • Identification of novel molecular marker involved in radio resistance in head and neck cancer 
  • Development of novel silymarine gel for therapeutic application in Oral Sub Mucous fibrosis
  • A Tiered Bio dosimetry Approach for the Management of Large Scale Radiological and Nuclear Emergencies
  • Role of collagen dressing in radiation dermatitis in breast Cancer patients
  • Role of swallowing exercises in relieving treatment induced Dysphagia in chemo radiation of head and neck cancer patients
  • Role of curcumin in potentiating therapeutic effect of taxol Based chemotherapy
  • Pharmacogenetic study on oral capecitabine in colo-rectal Cancer patients
  • Palliative benefit of electrochemotherapy with bleomycin in Cutaeous recurrences in head and neck and breast cancer patients
  • Radiation biomarkers in ca prostate 
  • Estimation of prevalence of urinary morbidity in patients with non-metastatic cervical cancers and to co-relate with various tumor related clinic-pathological factors
  • Estimation of prevalence of urinary morbidity in patients  with non-metastatic cervical cancer and to correlate with various tumor related  and clinico-pathological factors
  • Dosimetric analysis of VMAT plans for carcinoma chest wall 
  • A study to analysis the correlation between plan complexity score and gamma analysis for IMRT and VMAT technique 
  • Characterization of matrix evolution
  • Comparison of biological and physical optimization in carcinoma prostate

Call : 044 -4592 8650, Ext.No. 209

Email : [email protected]